Frank C Bandiera1, William Arguelles2, Marc Gellman2, Sheila F Castañeda3, Janice Barnhart4, Patricia Gonzalez5, Elena L Navas-Nacher6, Hugo Salgado5, Gregory A Talavera5, Neil Schneiderman2, David J Lee7. 1. Department of Epidemiology, University of Texas School of Public Health, Dallas, TX; frank.bandiera@utsouthwestern.edu. 2. Department of Psychology, University of Miami, Coral Gables, FL; 3. Institute for Behavioral and Community Health, San Diego State University, San Diego, CA; 4. Yeshiva University, New York, NY; 5. San Diego State University, San Diego, CA; 6. Northwestern University, Evanston, IL; 7. Department of Public Health Sciences, University of Miami School of Medicine, Miami, FL.
Abstract
INTRODUCTION: In the present study, we investigated associations among cigarette smoking, smoking cessation treatment, and depressive symptoms in Hispanic/Latino adults. METHODS: The multisite prospective population-based Hispanic Community Health Study/Study of Latinos (HCHS/SOL) enrolled a cohort of Hispanic/Latino adults (aged 18-74) from diverse backgrounds (n = 16,412) in 4U.S. communities (Chicago, San Diego, Miami, and Bronx). Households were selected using a stratified 2-stage probability sampling design and door-to-door recruitment, and sampling weights calibrated to the 2010U.S. Population Census. Hispanic/Latino individuals of Dominican, Central American, South American, Cuban, Mexican, and Puerto Rican background were considered. Cigarette smoking, smoking cessation treatment, and depressive symptoms were measured by self-report. RESULTS: Results indicated that current smokers had greater odds for significant depressive symptoms (CES-D score ≥ 10) than never smokers in all Hispanic background groups [odds ratio (OR) > 1.5]. Depressed persons were not more likely to receive prescribed smoking cessation medications from a doctor (OR = 1.43, 95% CI = 0.98-2.08), take over-the-counter medications (OR = 1.11, 95% CI = 0.75-1.66), or receive psychotherapy (OR = 1.02, 95% CI = 0.57-1.85). CONCLUSIONS: In conclusion, these findings suggest that the positive association between smoking status and depressive symptoms is present in all examined Hispanic/Latino background groups.
INTRODUCTION: In the present study, we investigated associations among cigarette smoking, smoking cessation treatment, and depressive symptoms in Hispanic/Latino adults. METHODS: The multisite prospective population-based Hispanic Community Health Study/Study of Latinos (HCHS/SOL) enrolled a cohort of Hispanic/Latino adults (aged 18-74) from diverse backgrounds (n = 16,412) in 4U.S. communities (Chicago, San Diego, Miami, and Bronx). Households were selected using a stratified 2-stage probability sampling design and door-to-door recruitment, and sampling weights calibrated to the 2010U.S. Population Census. Hispanic/Latino individuals of Dominican, Central American, South American, Cuban, Mexican, and Puerto Rican background were considered. Cigarette smoking, smoking cessation treatment, and depressive symptoms were measured by self-report. RESULTS: Results indicated that current smokers had greater odds for significant depressive symptoms (CES-D score ≥ 10) than never smokers in all Hispanic background groups [odds ratio (OR) > 1.5]. Depressed persons were not more likely to receive prescribed smoking cessation medications from a doctor (OR = 1.43, 95% CI = 0.98-2.08), take over-the-counter medications (OR = 1.11, 95% CI = 0.75-1.66), or receive psychotherapy (OR = 1.02, 95% CI = 0.57-1.85). CONCLUSIONS: In conclusion, these findings suggest that the positive association between smoking status and depressive symptoms is present in all examined Hispanic/Latino background groups.
Authors: Pablo Denes; Daniel B Garside; Donald Lloyd-Jones; Natalia Gouskova; Elsayed Z Soliman; Robert Ostfeld; Zhu-Ming Zhang; Alvaro Camacho; Ronald Prineas; Leopoldo Raij; Martha L Daviglus Journal: Am J Cardiol Date: 2013-09-19 Impact factor: 2.778
Authors: Susan Redline; Daniela Sotres-Alvarez; Jose Loredo; Martica Hall; Sanjay R Patel; Alberto Ramos; Neomi Shah; Andrew Ries; Raanan Arens; Janice Barnhart; Marston Youngblood; Phyllis Zee; Martha L Daviglus Journal: Am J Respir Crit Care Med Date: 2014-02-01 Impact factor: 21.405
Authors: Paul D Sorlie; Larissa M Avilés-Santa; Sylvia Wassertheil-Smoller; Robert C Kaplan; Martha L Daviglus; Aida L Giachello; Neil Schneiderman; Leopoldo Raij; Gregory Talavera; Matthew Allison; Lisa Lavange; Lloyd E Chambless; Gerardo Heiss Journal: Ann Epidemiol Date: 2010-08 Impact factor: 3.797
Authors: Lisa M Lavange; William D Kalsbeek; Paul D Sorlie; Larissa M Avilés-Santa; Robert C Kaplan; Janice Barnhart; Kiang Liu; Aida Giachello; David J Lee; John Ryan; Michael H Criqui; John P Elder Journal: Ann Epidemiol Date: 2010-08 Impact factor: 3.797
Authors: Miguel Ángel Cano; Marcel A de Dios; Virmarie Correa-Fernández; Sarah Childress; Jocelyn L Abrams; Angelica M Roncancio Journal: Addict Behav Date: 2017-03-27 Impact factor: 3.913
Authors: Yasuyuki Honda; Yejin Mok; Lena Mathews; Jeremy R Van't Hof; Gail Daumit; Anna Kucharska-Newton; Elizabeth Selvin; Thomas Mosley; Josef Coresh; Kunihiro Matsushita Journal: Atherosclerosis Date: 2021-05-09 Impact factor: 6.847